The significant difference in ratio plasma/serum PAI-1 between lean controls and T2D patients or obese non-diabetic subjects may indicate a different source of PAI-1 or increased platelet contribution to plasma PAI-1. The gene discussed is SERPINE1; the disease is type 2 diabetes mellitus.